SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001410578-19-000703
Filing Date
2019-08-07
Accepted
2019-08-07 16:52:26
Documents
15
Period of Report
2019-08-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv526852_8k.htm   iXBRL 8-K 31537
2 EXHIBIT 1.1 tv526852_ex1-1.htm EX-1.1 265712
3 EXHIBIT 5.1 tv526852_ex5-1.htm EX-5.1 12122
4 GRAPHIC tv526852_img001.jpg GRAPHIC 5648
  Complete submission text file 0001410578-19-000703.txt   556885

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ptct-20190807.xsd EX-101.SCH 3181
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptct-20190807_lab.xml EX-101.LAB 33476
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptct-20190807_pre.xml EX-101.PRE 21955
8 EXTRACTED XBRL INSTANCE DOCUMENT tv526852_8k_htm.xml XML 3500
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 191006197
SIC: 2834 Pharmaceutical Preparations